Hyderabad, Nov 8: Laurus Labs Limited, a leading research and development driven pharmaceutical company has completed the US Food and Drug Administration (USFDA) inspection of its Unit – 2 (FDF and API integrated facility), located at APSEZ in Atchutapuram, Visakhapatnam of Andhra Pradesh.
The two observations are procedural in nature, the pharmaceutical company said in a release here on Friday.
This is a product pre-approval audit by USFDA, and no data integrity issues were observed in the inspection.
The inspection was carried out from November 4 and ended today. (UNI)